Holoclara Inc.
PrivateLast Round
Series A
Jun 27, 2024
Total Funding Raised
$16.26M
Company Overview
Holoclara Inc. is a biotechnology company that develops immunotherapies for autoimmune and allergic disorders. The company was founded in 2017 by physician-scientist Andrea Choe and is based in the Los Angeles area. Holoclara is pioneering the development of orally available, symbiont-derived therapies, specifically mining immunomodulatory molecules from gut-dwelling roundworms. This approach is based on decades of preclinical data indicating the therapeutic efficacy of these molecules across a range of diseases. In June 2024, the company announced it had raised $16 million in a Series A financing round to advance its therapies into clinical development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Holoclara Inc. Comps
Public and private peers based on sector, stage, and business model.
Holoclara Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 27, 2024 | ||||
| Grant | Apr 15, 2023 | ||||
| Seed | May 9, 2017 |
Holoclara Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A |
| NIH RADx | Grant |
| Freeflow Ventures | Series A |
| Kairos Ventures | Seed |
| BOLD Capital Partners | Series A |
| SV Latam Capital | Series A |
| National Heart, Lung, and Blood Institute | Grant |
Holoclara Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Holoclara Inc.'s valuation, stock price, and market status.
